hxdbzxy
Medical Properties Trust (NYSE:MPW) is a global REIT that specializes in owning acute care hospitals and a small number of other types of healthcare facilities. The company's stock outperformed the S&P 500 and the MSCI REIT Index from 2018
Medical Properties Trust: Get Around Equity Risks With 10% Yielding Debt
Summary
- Medical Properties Trust is a REIT whose stock crashed to Earth in 2022.
- In order to sustain the dividend, the company will need to raise capital.
- Different capital raise options will dilute shareholders, but bondholders should remain isolated from those actions.
About My Writing: I am currently focused on income investing through either common shares, preferred shares, or bonds. I will occasionally break away and write about the economy at large or a special situation involving a company I've been researching in. I target two articles per week for publication on Monday and Tuesday.About My Background: Bachelors in history/political science, Masters in Business Administration with a specialization in Finance and Economics. I enjoy numbers. I have been investing since 2000. Professionally, I am the CEO of an independent living retirement community in Illinois.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
I may initiate a position in Medical Properties debt maturing in 2029 within the next 72 hours.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.